Long-term Equity-based Compensation Plans (Tables)

9 Months Ended

Sep. 30, 2013

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

The assumptions used in the Black-Scholes pricing model for options granted during the nine months ended September 30, 2013 and 2012 were as follows:



	Nine Months Ended
	Sep 30, 2013					Sep 30, 2012
Range of Valuation Assumptions
Expected Volatility	39.10	%	-	48.23	%	29.36	%	-	53.84	%
Risk-free Interest Rate	0.62		-	1.38		0.16		-	1.26
Expected Dividend Yield	2.83		-	3.00		2.92		-	3.26
Weighted-Average Expected Life in Years
Employee Grants	4		-	7		1		-	7
Director Grants	6					6

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

Option and stock appreciation right activity for the nine months ended September 30, 2013 is presented below:



	Shares Subject to Options		Weighted- Average Exercise Price Per Share ($)		Weighted- Average Remaining Contractual Life (in Years)	Aggregate Intrinsic Value ($ in Millions)
Outstanding at Beginning of the Year	3,192,054		$	40.53
Granted	283,750		33.20
Exercised	(190,000	)	24.77
Forfeited or Expired	(493,756	)	42.55
Outstanding at September 30, 2013	2,792,048		$	40.50	3.89	$	4.3
Vested and Expected to Vest at September 30, 2013	2,759,163		$	40.61	3.84	$	4.2
Exercisable at September 30, 2013	2,466,795		$	41.72	3.26	$	3.5

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

Information pertaining to options and stock appreciation rights outstanding at September 30, 2013 is presented below:



					Outstanding				Exercisable
Range of Exercise Prices					Shares Subject to Options	Weighted- Average Exercise Price Per Share ($)		Weighted- Average Remaining Contractual Life (in Years)	Shares Subject to Options	Weighted- Average Exercise Price Per Share ($)
$	10.00	-	$	15.00	26,750	$	13.55	5.35	26,750	$	13.55
15.01		-	20.00		8,000	16.48		5.60	8,000	16.48
20.01		-	25.00		116,250	23.58		6.34	111,250	23.63
25.01		-	30.00		475,250	28.74		7.68	322,062	28.61
30.01		-	35.00		262,750	33.17		9.37	95,685	32.67
35.01		-	40.00		326,000	37.22		4.11	326,000	37.22
40.01		-	45.00		360,618	43.58		0.86	360,618	43.58
45.01		-	50.00		979,722	48.64		2.07	979,722	48.64
50.01		-	55.00		236,708	50.51		0.61	236,708	50.51
10.00		-	55.00		2,792,048	40.50		3.89	2,466,795	41.72

Performance-Based Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]

Activity related to nonvested performance-based restricted stock for the nine months ended September 30, 2013 was as follows:



	Performance-Based Restricted Shares		Weighted- Average Grant-Date Fair Value Per Share
Nonvested Balance at Beginning of the Year	187,075		$	36.70
Granted	70,675		42.12
Vested	(53,118	)	33.14
Forfeited	(24,632	)	38.95
Nonvested Balance at End of Period	180,000		39.57

Time-Based Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]

Activity related to nonvested time-based restricted stock for the nine months ended September 30, 2013 was as follows:



	Time-Based Restricted Shares		Weighted- Average Grant-Date Fair Value Per Share
Nonvested Balance at Beginning of the Year	126,349		$	26.19
Granted	71,625		29.95
Vested	(57,990	)	25.03
Forfeited	(31,694	)	26.88
Nonvested Balance at End of Period	108,290		29.10

- Definition

Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate.

+ References+ Details